Literature DB >> 8290407

Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent?

S Tariq1, S M Tariq.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8290407      PMCID: PMC2399956          DOI: 10.1136/pgmj.69.816.775

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  71 in total

1.  Effects of methotrexate on clinical and immunological parameters in refractory rheumatoid arthritis: a prospective study.

Authors:  Y N Singh; M Sharma; R J Singh; A Kumar; R Malaviya; A N Malaviya
Journal:  Br J Rheumatol       Date:  1991-02

2.  Methotrexate therapy and pulmonary disease.

Authors:  C S Everts; J L Westcott; D G Bragg
Journal:  Radiology       Date:  1973-06       Impact factor: 11.105

Review 3.  Methotrexate guidelines--revised.

Authors:  H H Roenigk; R Auerbach; H I Maibach; G D Weinstein
Journal:  J Am Acad Dermatol       Date:  1982-02       Impact factor: 11.527

4.  [Low dose methotrexate therapy in rheumatoid arthritis].

Authors:  T Shinozawa; H Akama; Y Matsushita; H Tanaka; H Yamada; Y Suzuki; Y Ichikawa; M Homma
Journal:  Ryumachi       Date:  1990-06

5.  Adverse experience with methotrexate during 176 weeks of a longterm prospective trial in patients with rheumatoid arthritis.

Authors:  D E Furst; N Erikson; L Clute; R Koehnke; L F Burmeister; J A Kohler
Journal:  J Rheumatol       Date:  1990-12       Impact factor: 4.666

6.  Pancytopenia after accidental overdose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis.

Authors:  M A Brown; A B Corrigan
Journal:  Med J Aust       Date:  1991-10-07       Impact factor: 7.738

7.  Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. A controlled study.

Authors:  R Rau; G Herborn; T Karger; D Werdier
Journal:  Arthritis Rheum       Date:  1991-10

8.  Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial.

Authors:  M E Jeurissen; A M Boerbooms; L B van de Putte; W H Doesburg; J Mulder; J J Rasker; M W Kruijsen; J F Haverman; H J van Beusekom; W H Muller
Journal:  Arthritis Rheum       Date:  1991-08

9.  Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.

Authors:  A W Craft; H Kay; D N Lawson; T J McElwain
Journal:  Br Med J       Date:  1977-12-10

10.  Methotrexate and histologic hepatic abnormalities: a meta-analysis.

Authors:  Q E Whiting-O'Keefe; K H Fye; K D Sack
Journal:  Am J Med       Date:  1991-06       Impact factor: 4.965

View more
  2 in total

1.  Methotrexate pneumonitis in a patient with rheumatoid arthritis.

Authors:  R Clearkin; P A Corris; S H Thomas
Journal:  Postgrad Med J       Date:  1997-09       Impact factor: 2.401

Review 2.  Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis.

Authors:  C P Rains; S Noble; D Faulds
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.